Is the Wegovy pill the first oral GLP-1 weight loss pill?
Yes, the Wegovy pill is the first oral GLP-1 medicine approved in the US specifically for weight loss. It contains semaglutide and is designed to support weight management in adults with obesity, or adults who are overweight and have at least one weight-related health condition.
However, it is not the first oral GLP-1 medicine overall. Rybelsus came before it as an oral semaglutide tablet for adults with type 2 diabetes. The key difference is that Rybelsus is licensed for blood sugar control in type 2 diabetes, while the Wegovy pill is focused on weight management.
In the UK, Rybelsus is already available as an oral semaglutide medicine for type 2 diabetes. The Wegovy pill is expected to become available in the UK, but no confirmed UK launch date has been set yet.
Key points:
- The Wegovy pill is the first oral GLP-1 medicine approved in the US specifically for weight loss.
- Rybelsus was available before Wegovy as an oral semaglutide tablet for type 2 diabetes.
- The main difference is that Wegovy is for weight management, while Rybelsus is for type 2 diabetes.
- The Wegovy pill is expected in the UK, but no confirmed launch date has been set yet.
This text has been fact-checked for accuracy by Sorin Romaniuc, Pharmacist at medino.